...
首页> 外文期刊>Archives of virology >The carboxy-terminal half of nonstructural protein 3A is not essential for foot-and-mouth disease virus replication in cultured cell lines
【24h】

The carboxy-terminal half of nonstructural protein 3A is not essential for foot-and-mouth disease virus replication in cultured cell lines

机译:非结构蛋白3A的羧基末端一半对于培养的细胞系中的口蹄疫病毒复制不是必需的

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In foot-and-mouth disease (FMD)-endemic parts of the globe, control is mainly implemented by preventive vaccination with an inactivated purified vaccine. ELISAs detecting antibodies to the viral nonstructural proteins (NSP) distinguish FMD virus (FMDV)-infected animals in the vaccinated population (DIVA). However, residual NSPs present in the vaccines are suspected to be a cause of occasional false positive results, and therefore, an epitope-deleted negative marker vaccine strategy is considered a more logical option. In this study, employing a serotype Asia 1 FMDV infectious cDNA clone, it is demonstrated that while large deletions differing in size and location in the carboxy-terminal half of 3A downstream of the putative hydrophobic membrane-binding domain (deletion of residues 86-110, 101-149, 81-149 and 81-153) are tolerated by the virus without affecting its infectivity in cultured cell lines, deletions in the amino-terminal half (residues 5-54, 21-50, 21-80, 55-80 and 5-149) containing the dimerization and the transmembrane domains are deleterious to its multiplication. Most importantly, the virus could dispense with the entire carboxy-terminal half of 3A (residues 81-153) including the residues involved in the formation of the 3A-3B(1) cleavage junction. The rescue of a replication-competent FMDV variant carrying the largest deletion ever in 3A (residues 81-153) and the fact that the deleted region contains a series of linear B-cell epitopes inspired us to devise an indirect ELISA based on a recombinant 3A carboxy-terminal fragment and to evaluate its potential to serve as a companion diagnostic assay for differential serosurveillance if the 3A-truncated virus is used as a marker vaccine.
机译:在全球口蹄疫(FMD)流行地区,控制主要通过使用灭活的纯化疫苗进行预防接种来实现。 ELISA检测到的病毒非结构蛋白(NSP)抗体可区分接种人群(DIVA)中受口蹄疫病毒(FMDV)感染的动物。但是,疫苗中存在的残留NSP被怀疑是偶尔出现假阳性结果的原因,因此,删除表位的阴性标记疫苗策略被认为是更合乎逻辑的选择。在这项研究中,使用亚洲1型FMDV血清型感染性cDNA克隆,证明了大的缺失在大小和位置上在假定的疏水性膜结合结构域下游3A的羧基末端一半处有所不同(删除残基86-110) (101-149、81-149和81-153)被该病毒耐受,而不影响其在培养细胞系中的感染性,氨基末端一半的缺失(残基5-54、21-50、21-80、55-包含二聚化和跨膜结构域的80和5-149)对其繁殖有害。最重要的是,病毒可以免除3A的整个羧基末端部分(残基81-153),包括参与3A-3B(1)裂解连接形成的残基。具有复制能力的FMDV变异体的挽救,该变异体带有3A中最大的缺失(残基81-153),并且缺失的区域包含一系列线性B细胞表位这一事实促使我们设计基于重组3A的间接ELISA羧基末端片段,并评估其潜力,如果将3A截短的病毒用作标记疫苗,则可以用作差异血清监测的辅助诊断分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号